Amount: up to $500,000 of eligible costs
The Life Sciences Innovation Fund (LSIF) is an early-stage co-investment fund that supports companies in Life Sciences and Healthcare Technologies sectors related to human health.
The fund is aimed at addressing the unique challenges faced by life sciences entrepreneurs moving innovative and capital-intensive investments from a conceptual stage through to commercialization. It is best suited for life sciences and healthcare technologies companies related to human health.
Eligibility Criteria:
- Are Ontario or Canadian incorporated for-profit companies headquartered in Ontario
- Currently raising a pre-seed or seed investments (total round sizes ranging from $1 million to $5 million)
- Have raised less than $3 million in third-party capital
Amount
Eligible companies will receive up to $500,000 in early stage risk capital to scale their made-in-Ontario health solution both at home and in global markets. This will further grow the sector and strengthen its competitiveness in key areas such as cancer treatment, regenerative medicine, neuroscience and medical technologies.
